This poster, presented in December 2015 at the 57th American Society of Hematology annual meeting in Orlando, Florida, shows recent trends in expert treatment recommendations and practice patterns of clinicians who used an innovative online treatment decision tool for mantle cell lymphoma. Data generated from this online tool suggest that many clinicians chose treatment options that were not selected by the experts for both newly diagnosed MCL and relapsed/refractory disease. Furthermore, in some cases, up to 23% of clinicians indicated that they were unsure of their treatment approach for individual patients. Clinicians indicated that this tool either confirmed or changed their treatment choice in 76% of cases, indicating a substantial impact on clinical decision making.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.